GH

SEC source: 0001652956-26-000004 · wk-form4_1767992993.xml · nonDerivative · entry 1

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,710

F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.230 to $112.175. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · derivative · entry 12

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,684

Underlying: Common Stock · 2,526 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · derivative · entry 11

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,688

Underlying: Common Stock · 5,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · derivative · entry 10

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,002

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · derivative · entry 9

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,428 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · derivative · entry 7

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,786

Underlying: Common Stock · 1,928 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 6

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,870

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 5

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,032

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 4

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,506

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 3

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,818

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 2

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001871615-26-000002 · wk-form4_1767653972.xml · nonDerivative · entry 1

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001753159-26-000002 · wk-form4_1767653791.xml · derivative · entry 6

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,989

Underlying: Common Stock · 23,997 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001753159-26-000002 · wk-form4_1767653791.xml · nonDerivative · entry 4

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,013,457

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001753159-26-000002 · wk-form4_1767653791.xml · nonDerivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,024,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · derivative · entry 12

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,476

Underlying: Common Stock · 2,925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · derivative · entry 11

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,688

Underlying: Common Stock · 5,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · derivative · entry 10

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,002

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · derivative · entry 9

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,792 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · derivative · entry 7

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,922

Underlying: Common Stock · 974 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 6

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,714

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 5

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 4

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,778

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 3

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,090

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 2

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001737840-26-000002 · wk-form4_1767654103.xml · nonDerivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001652956-26-000002 · wk-form4_1767654064.xml · derivative · entry 5

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,615

Underlying: Common Stock · 2,659 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001652956-26-000002 · wk-form4_1767654064.xml · derivative · entry 4

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,898

Underlying: Common Stock · 14,896 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001652956-26-000002 · wk-form4_1767654064.xml · nonDerivative · entry 3

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,021

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001652956-26-000002 · wk-form4_1767654064.xml · nonDerivative · entry 2

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001652956-26-000002 · wk-form4_1767654064.xml · nonDerivative · entry 1

Monroe Terilyn J. · CIK 0001652956 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · derivative · entry 12

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,615

Underlying: Common Stock · 2,659 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · derivative · entry 11

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,688

Underlying: Common Stock · 5,688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · derivative · entry 10

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,002

Underlying: Common Stock · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · derivative · entry 9

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,714 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · derivative · entry 7

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,143

Underlying: Common Stock · 1,714 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 6

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,927

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 5

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,449

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 4

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 3

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 2

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,435

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562135-26-000002 · wk-form4_1767653920.xml · nonDerivative · entry 1

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 12

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,961

Underlying: Common Stock · 1,995 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 11

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,698

Underlying: Common Stock · 3,696 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 10

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,252

Underlying: Common Stock · 1,083 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 9

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,856 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · derivative · entry 7

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,821

Underlying: Common Stock · 1,607 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 6

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,524

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 5

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001927831-26-000002 · wk-form4_1767654008.xml · nonDerivative · entry 4

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,921

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.